← Leaderboards
Ruben Martinez Barricarte
Vanderbilt University Medical Center
$3,893,863
Attributed
$3,893,863
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,893,863 · 3
By mechanism
R01$3,418,113 · 2
R21$475,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- David W Haas$38,631,058
- Spyros A Kalams$30,057,725
- Stephany Norah Duda$15,549,072
- Pedro Enrique Cahn$9,706,017
- Bryan Earl Shepherd$9,231,669
Others in their field
Other Rising Stars on “Future”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Mari Ostendorf · University Of Washington$51,931,230
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Eric M Benway · Woods Hole Oceanographic Institution$32,293,242
- Walt Lee$25,884,232
- Cyrus Wadia · Activate Global, Inc.$24,000,000
Research focus
FutureAutoimmunityBiologicalCellsPreventImmunologicsMutationMalignant NeoplasmsGenesImpairmentCongenital ImmunodeficiencyImmunityProteinsImmunoregulationSamplingMediatingLearningMendelian DisorderCell LineInhibitorExperimental StudyImmune System DiseasesImmuneGenetic Disorder Diagnosis
Grant awards (8)
The role of SERPINB1 in T cell function and its contribution to human diseases$646,268
R01 · FY2025 · AI · contact PI
Gain-of-function complement activators as a new class of immunotherapeutic molecules$495,105
R01 · FY2025 · CA · contact PI
The role of SERPINB1 in T cell function and its contribution to human diseases$646,268
R01 · FY2024 · AI · contact PI
Gain-of-function complement activators as a new class of immunotherapeutic molecules$470,349
R01 · FY2024 · CA · contact PI
The role of SERPINB1 in T cell function and its contribution to human diseases$665,018
R01 · FY2023 · AI · contact PI
Gain-of-function complement activators as a new class of immunotherapeutic molecules$495,105
R01 · FY2023 · CA · contact PI
Genetic and immunological dissection of isolated Nocardiosis$259,500
R21 · FY2023 · AI · contact PI
Genetic and immunological dissection of isolated Nocardiosis$216,250
R21 · FY2022 · AI · contact PI